XGN Similar Chart Price Prediction
The price of XGN is predicted to go up 8.83%, based on the high correlation periods with FPI. The similarity of these two price pattern on the periods is 95.72%.
XGN
FPI
Up: 8.83%Similarity: 95.72%
XGN Revenue Forecast
XGN EPS Forecast
XGN FAQs
What is bull’s view on XGN?
What is bear's view on XGN?
What is XGN revenue forecast for next quarter？
What is XGN eps forecast for next quarter？
XGN Analyst's Forecast
Kyle Mikson
Canaccord Genuity
Strong Buy
2025-01-03
Price Target
$5 → $7
Upside
+95.53%
Canaccord raised the firm's price target on Exagen to $7 from $5 and keeps a Buy rating on the shares. The firm previewed its coverage in the Diagnotstics and Tools universe for the year and it believes the outlook appears move favorable in 2025, albeit weighed toward the back end of the year. As the group underperformed in 2024 they acknowledege investors may be weary, but companies with possible meaningful product launches include Exagen could support a return to improved revenue growth.
